UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2017

Commission File Number 333-209744

TODOS MEDICAL LTD.

(Translation of registrant's name into English)

1 Hamada Street

Rehovot, Israel

+972-8-633-3964

 (Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

x Form 20-F      ¨ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Notice of Allowance of US Patent Application

On June 15, 2017, Todos Medical Ltd. (the “Company”) received a notice of allowance from the United States Patent and Trademark Office (the “PTO”) with regard to US Patent Application 14/116,506, an application regarding analysis of an infrared (“IR”) spectrum of a blood plasma sample to indicate the presence of a solid tumor in the gastrointestinal tract. The issue fee payment is due by September 15, 2017, and the Company expects the patent to issue within two months of the payment of the issue fee. The Company believes the anticipated issuance of this patent is an important milestone in protecting the Company’s technology. 

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TODOS MEDICAL LTD.
	By:	/s/ Rami Zigdon
		Name: Rami Zigdon
		Title:   Chief Executive Officer
Date: June 22, 2017